These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32397795)

  • 1. Confronting the reality of COVID.
    Piepoli MF
    Eur J Prev Cardiol; 2020 May; 27(8):787-788. PubMed ID: 32397795
    [No Abstract]   [Full Text] [Related]  

  • 2. Promising effects of exercise on the cardiovascular, metabolic and immune system during COVID-19 period.
    Jesus I; Vanhee V; Deramaudt TB; Bonay M
    J Hum Hypertens; 2021 Jan; 35(1):1-3. PubMed ID: 32943741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'.
    Piepoli MF
    Eur J Prev Cardiol; 2020 Jul; 27(10):1011-1013. PubMed ID: 32583735
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19.
    Pezel T; Lima JAC
    Arch Cardiovasc Dis; 2020; 113(6-7):378-380. PubMed ID: 32586675
    [No Abstract]   [Full Text] [Related]  

  • 5. Crucial Conversations With Patients in the Era of COVID-19.
    Siropaides CH; Sulistio MS; Reimold SC
    Circulation; 2020 Jul; 142(3):191-193. PubMed ID: 32374630
    [No Abstract]   [Full Text] [Related]  

  • 6. Heartbeat: taking care of patients with cardiovascular disease during a pandemic.
    Otto CM
    Heart; 2020 Sep; 106(17):1283-1285. PubMed ID: 32788288
    [No Abstract]   [Full Text] [Related]  

  • 7. The COVID-19 pandemic: lifestyle and cardiovascular risk factors.
    Bhatnagar D
    Curr Opin Lipidol; 2021 Feb; 32(1):71-73. PubMed ID: 33315619
    [No Abstract]   [Full Text] [Related]  

  • 8. [ANMCO Position paper: Role of cardiology in the management of health needs in the post-COVID-19 era].
    Murrone A; Colivicchi F; Roncon L; Caldarola P; Amodeo V; Urbinati S; Di Lenarda A; Valente S; Aspromonte N; Cipriani M; Domenicucci S; Francese GM; Imazio M; Scotto di Uccio F; Scherillo M; Di Pasquale G; Gulizia MM; Gabrielli D
    G Ital Cardiol (Rome); 2020 Jul; 21(7):509-513. PubMed ID: 32555566
    [No Abstract]   [Full Text] [Related]  

  • 9. A close-up on COVID-19 and cardiovascular diseases.
    Li G; Hu R; Gu X
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1057-1060. PubMed ID: 32423664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editor's presentation: Do we really need biomarkers for cardiovascular risk prediction?
    Piepoli MF
    Eur J Prev Cardiol; 2020 Apr; 27(6):563-565. PubMed ID: 32268809
    [No Abstract]   [Full Text] [Related]  

  • 11. Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia.
    Adikari DH; Kushwaha VV; Jepson NS
    Heart Lung Circ; 2020 Aug; 29(8):1109-1111. PubMed ID: 32653299
    [No Abstract]   [Full Text] [Related]  

  • 12. How is the cardiovascular patient managed during Covid-19 pandemic? A report from the frontline.
    Cortese B
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):E565. PubMed ID: 32433798
    [No Abstract]   [Full Text] [Related]  

  • 13. [ANMCO Position paper: Cardiological outpatient activities in the transition phase of the COVID-19 pandemic].
    Valente S; Colivicchi F; Francese MG; Di Lenarda A; Roncon L; Murrone A; Caldarola P; Bilato C; Amodeo E; Aspromonte N; Cipriani M; Domenicucci S; Imazio M; Scotto di Uccio F; Urbinati S; Gulizia MM; Gabrielli D
    G Ital Cardiol (Rome); 2020 Aug; 21(8):584-588. PubMed ID: 32686782
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular health and COVID-19: time to reinvent our systems and rethink our research priorities.
    Watkins DA
    Heart; 2020 Dec; 106(24):1870-1872. PubMed ID: 33144390
    [No Abstract]   [Full Text] [Related]  

  • 15. Editor's presentation: Modifiers in cardiovascular risk estimation.
    Piepoli MF
    Eur J Prev Cardiol; 2020 Mar; 27(5):451-453. PubMed ID: 32172638
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular manifestations in severe and critical patients with COVID-19.
    Chen Q; Xu L; Dai Y; Ling Y; Mao J; Qian J; Zhu W; Di W; Ge J
    Clin Cardiol; 2020 Jul; 43(7):796-802. PubMed ID: 32562427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal Medicine for Slowing Aging and Cardiovascular Risk: Mechanisms and Safety.
    Liu Y; Liu Y
    Curr Vasc Pharmacol; 2020; 18(4):305-306. PubMed ID: 32519621
    [No Abstract]   [Full Text] [Related]  

  • 18. SCAI initiatives during the COVID-19 pandemic.
    Mahmud E
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):995-996. PubMed ID: 32562454
    [No Abstract]   [Full Text] [Related]  

  • 19. From geriatric cardiology to 'cardio-geriatric' prevention and rehabilitation: Need for a new core curriculum?
    Pedretti RF; Ambrosetti M; Sarzi Braga S
    Eur J Prev Cardiol; 2020 Mar; 27(5):550-552. PubMed ID: 31537122
    [No Abstract]   [Full Text] [Related]  

  • 20. The 2016 Joint European Prevention Guidelines and the uses of polypills: Time to update the evidence.
    Webster R; Grobbee D; Rodgers A
    Eur J Prev Cardiol; 2020 Mar; 27(4):437-440. PubMed ID: 31446790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.